Analgesia Evaluation of an Ultrasound-guided Technique for Inguinal Hernia Surgery in Children in Children
NCT ID: NCT06883370
Last Updated: 2025-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
32 participants
INTERVENTIONAL
2023-12-01
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study was designed obtain the analgesic efficacy of ropivacaine 0.375% for ultrasound-guided (USG) TFP block for paediatric patients undergoing laparoscopic inguinal hernia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Comparison of the Transversalis Fascia Plane Block With Ilioinguinal/Iliohypogastric Nerve Block
NCT03520907
Surgical Transversus Abdominis Plane Block in Pediatric Patients
NCT01548027
Transversalis Fascia Plane Block vs Transversus Abdominis Plane Block In Pediatric Surgeries
NCT06530147
The Efficacy of Transversalis Fascia Plane Block in Pediatric Inguinal Hernia Repair
NCT04272320
Transversalis Fascia Plane Block in Pediatric Patients
NCT06391528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All patients
All paediatric patients undergoing inguinal hernia repair
ultrasound-guided transversals fascia plane block with ropivacaine
using 0.375% ropivacaine of 0.4mls/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound-guided transversals fascia plane block with ropivacaine
using 0.375% ropivacaine of 0.4mls/kg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria: Parent's refusal, allergic to study drug
6 Months
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University of Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr
Role: PRINCIPAL_INVESTIGATOR
The National University of Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The National University of Malaysia
Kuala Lumpur, , Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JEPUKM-JEP-2023-518
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.